Pulmonary hypertension: Molecular aspects of current therapeutic intervention and future direction.

about

Pulmonary hypertension: Molecular aspects of current therapeutic intervention and future direction.

Item

http://www.wikidata.org/entity/Q47941425

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pulmonary hypertension: Molecu ...... rvention and future direction.

@en

Pulmonary hypertension: Molecu ...... rvention and future direction.

@nl

type

Item

label

Pulmonary hypertension: Molecu ...... rvention and future direction.

@en

Pulmonary hypertension: Molecu ...... rvention and future direction.

@nl

prefLabel

Pulmonary hypertension: Molecu ...... rvention and future direction.

@en

Pulmonary hypertension: Molecu ...... rvention and future direction.

@nl

P1476

Pulmonary hypertension: Molecu ...... ervention and future direction

@en

P2093

Amit K Arora

http://www.w3.org/2001/XMLSchema#string

Monika K Sachdeva

http://www.w3.org/2001/XMLSchema#string

Satyendra K Rajput

http://www.w3.org/2001/XMLSchema#string

Taruna K Arora

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial dysfunction and pharmacological treatment

Endothelial cell control of thrombosis

The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis

Pharmacotherapy for pulmonary hypertension

Role of platelet-derived growth factors in physiology and medicine

The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension.

Aberrant caveolin-1-mediated Smad signaling and proliferation identified by analysis of adenine 474 deletion mutation (c.474delA) in patient fibroblasts: a new perspective on the mechanism of pulmonary hypertension.

New approaches to the treatment of pulmonary hypertension: from bench to bedside.

Effects of 17β-estradiol and 2-methoxyestradiol on the oxidative stress-hypoxia inducible factor-1 pathway in hypoxic pulmonary hypertensive rats

TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.

P304

3794-3804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.26191

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

Arun K Sharma

P577

2017-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28926093

http://www.w3.org/2001/XMLSchema#string